Our Services
We provide complete IP Life-cycle services ranging from IP landscape, Freedom to operate analysis, validity analysis, IP Creation, IP Prosecution to IP Monetization, IP Litigation support and IP Management.
PATENTS
- Comprehensive patent searching with analysis &
opinion for:
i. Prior art
ii. Novelty
iii. Patentability
iv. Freedom to operate analysis (FTO)
v. Invalidation
vi. Litigation support
vii. White space analysis - Drafting provisional & complete patent specifications for India and
overseas - Filing and prosecuting applications at the Indian Patent Office
directly or in cooperation with our Indian associates - Filing and prosecuting applications internationally
in cooperation with our foreign associates
IP Strategy & Counselling
- Assessment and management of patent portfolio
- Advice on long-term IP strategy
- Risk identification, assessment & mitigation associated with
product launch - IP litigation strategy & execution (with our Indian/Foreign
associates) - IP and technology due diligence for acquisition targets
- Life Cycle Management
- Patent enforcement & monetization
- Advice on building an In-House IP team and IP processes
Product selection
- Product selection of Active Pharmaceutical Ingredient (API) and
Generics products - Opportunity identification for Para IV, First to File, First to market,
and 505(b)(2) opportunities - Identifying niche areas for IP-driven Business Development
IP training & awareness program
- We design and facilitate customized IP workshops and webinars
covering an array of topics based on the need of the client. - Representative audience groups include
i. Research & Academic Institutes
ii. In-House IP groups/Lawyers of multinational Pharma
companies
iii. Business and management teams - Topics covered
i. IPR in Healthcare
ii. Latest developments in Indian pharma patent litigation
iii. Repurposed drugs
iv. Balancing innovation & affordability and promoting
competition
v. Pharmaceutical Patents, Portfolio Management &
Unleashing the value of IP assets
vi. Importance of IP for Pharma/Biotech companies
vii. Basics of Patent
viii. Patentability criteria
ix. Patent application process
x. Regulatory pathways
xi. Generic Products/ 505(j) ANDA & Hatch Waxman act
xii. Innovative/differentiated products/
505(b)(2)
xiii. Freedom to operate analysis/Infringement (literal & DoE)
xiv. Latest updates on key judgements across US, Europe, India,
Australia & China
xv. Polymorph patents